Search Results

There are 12373 results for: content related to: Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >
  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile

    Movement Disorders

    Volume 23, Issue 16, 15 December 2008, Pages: 2398–2403, Christopher G. Goetz, John G. Nutt and Glenn T. Stebbins

    Article first published online : 21 NOV 2008, DOI: 10.1002/mds.22341

  3. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Article first published online : 21 OCT 2011, DOI: 10.1002/mds.23829

  4. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Karla Soares-Weiser, Claire B Irving and John Rathbone

    Published Online : 16 JUN 2010, DOI: 10.1002/14651858.CD000208

  5. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Article first published online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Article first published online: 10 NOV 2010

  6. Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1578–1594, Susan H. Fox, Anthony E. Lang and Jonathan M. Brotchie

    Article first published online : 27 JUL 2006, DOI: 10.1002/mds.20936

  7. Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S585–S598, Peter Jenner

    Article first published online : 9 SEP 2008, DOI: 10.1002/mds.22022

  8. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video-based analysis

    Movement Disorders

    Volume 24, Issue 3, 15 February 2009, Pages: 336–343, C. Warren Olanow, Jean-Michel Gracies, Christopher G. Goetz, A. Jon Stoessl, Thomas Freeman, Jeffrey H. Kordower, James Godbold and Jose A. Obeso

    Article first published online : 12 NOV 2008, DOI: 10.1002/mds.22208

  9. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 642–650, Susan H. Fox, Brian Henry, Micheal P. Hill, David Peggs, Alan R. Crossman and Jonathan M. Brotchie

    Article first published online : 16 JUL 2001, DOI: 10.1002/mds.1148

  10. Cholinergic medication for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Irina Tammenmaa, John McGrath, Eila ES Sailas and Karla Soares-Weiser

    Published Online : 12 MAY 2010, DOI: 10.1002/14651858.CD000207

  11. The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2084–2093, Tom H. Johnston, Susan H. Fox, Matthew J. Piggott, Juha-Matti Savola and Jonathan M. Brotchie

    Article first published online : 7 SEP 2010, DOI: 10.1002/mds.23172

  12. Benzodiazepines for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Paranthaman Sethupathi Bhoopathi and Karla Soares-Weiser

    Published Online : 12 MAY 2010, DOI: 10.1002/14651858.CD000205.pub2

  13. Calcium channel blockers for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Adib Essali, Hany Deirawan, Karla Soares-Weiser and Clive E Adams

    Published Online : 9 NOV 2011, DOI: 10.1002/14651858.CD000206.pub3

  14. Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque

    European Journal of Neuroscience

    Volume 37, Issue 5, March 2013, Pages: 831–838, Philippe Huot, Tom H. Johnston, Tessa Snoeren, James B. Koprich, Michael P. Hill, Susan H. Fox and Jonathan M. Brotchie

    Article first published online : 3 JAN 2013, DOI: 10.1111/ejn.12093

  15. Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?

    Movement Disorders

    Volume 22, Issue 1, January 2007, Pages: 1–9, John G. Nutt

    Article first published online : 6 SEP 2006, DOI: 10.1002/mds.21060

  16. Placebo influences on dyskinesia in Parkinson's disease

    Movement Disorders

    Volume 23, Issue 5, 15 April 2008, Pages: 700–707, Christopher G. Goetz, Eugene Laska, Christine Hicking, Philippe Damier, Thomas Müller, John Nutt, C. Warren Olanow, Olivier Rascol and Hermann Russ

    Article first published online : 3 JAN 2008, DOI: 10.1002/mds.21897

  17. Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 377–384, Kayhan A. Tayarani-Binazir, Michael J. Jackson, Sarah Rose, C. Warren Olanow and Peter Jenner

    Article first published online : 27 JAN 2010, DOI: 10.1002/mds.22960

  18. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease

    Movement Disorders

    C. Warren Olanow, Karl Kieburtz, Olivier Rascol, Werner Poewe, Anthony H. Schapira, Murat Emre, Helena Nissinen, Mika Leinonen and Fabrizio Stocchi, Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators

    Article first published online : 29 APR 2013, DOI: 10.1002/mds.25364

  19. Age of Parkinson's disease onset as a predictor for the development of dyskinesia

    Movement Disorders

    Volume 25, Issue 9, 15 July 2010, Pages: 1177–1182, Stephen Ku and Graham A. Glass

    Article first published online : 22 MAR 2010, DOI: 10.1002/mds.23068

  20. Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 631–641, Eleni C. Maratos, Michael J. Jackson, Ronald K. B. Pearce and Peter Jenner

    Article first published online : 11 JUL 2001, DOI: 10.1002/mds.1149

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >